Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06457724
Other study ID # 48/2022
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date December 31, 2024

Study information

Verified date June 2024
Source University of L'Aquila
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This RCT investigates the impact of an oral supplement containing the probiotic Lactobacillus brevis CD2 on various salivary indicators of oral health. Participants will be randomly assigned to either the probiotic supplement group or a placebo group. The primary objective is to assess changes in salivary biomarkers, including salivary pH and buffer capacity; microbial composition using microbiome next-generation sequencing (NGS); and clinical oral inflammatory markers, such as full mouth bleeding score and full mouth plaque score, over a 4-week period. By comparing these indicators between the two groups, the study aims to determine the efficacy of Lactobacillus brevis CD2 in promoting oral health and potentially preventing oral diseases.


Description:

This RCT is designed to investigate the impact of an oral supplement containing the probiotic Lactobacillus brevis CD2 on various salivary indicators of oral health. The study aims to provide robust evidence on the efficacy of this probiotic in promoting oral health and potentially preventing oral diseases. Study Design: Participants will be randomly assigned to one of two groups: the experimental group, which will receive the Lactobacillus brevis CD2 probiotic supplement, and the control group, which will receive a placebo. This random assignment ensures that the groups are comparable at the start of the trial, allowing for unbiased comparison of outcomes. Duration: The study will be conducted over a 4-week period, during which participants will adhere to their assigned supplement regimen. Primary Objectives: The primary objective of this RCT is to assess the impact of Lactobacillus brevis CD2 on several key indicators of oral health, measured through salivary biomarkers, microbial composition, and clinical oral inflammatory markers. Salivary Biomarkers: Salivary pH: The acidity or alkalinity of saliva, which can influence oral health by affecting the growth of bacteria and the integrity of tooth enamel. Buffer Capacity: The ability of saliva to neutralize acids, which is crucial for maintaining a healthy oral environment and preventing dental caries. Microbial Composition: The composition of the oral microbiome will be analyzed using next-generation sequencing (NGS). This advanced technique allows for a comprehensive assessment of the microbial populations present in the saliva, providing insights into how the probiotic supplement may alter the microbiome to support oral health. Clinical Oral Inflammatory Markers: Full Mouth Bleeding Score: A measure of gum inflammation and bleeding, which are indicators of gingivitis or periodontal disease. Full Mouth Plaque Score: A measure of the accumulation of dental plaque, which is a biofilm of bacteria that can lead to tooth decay and gum disease if not properly managed. Outcome Comparison: By comparing the changes in these indicators between the probiotic supplement group and the placebo group, the study aims to determine the efficacy of Lactobacillus brevis CD2. Significant improvements in the probiotic group compared to the placebo group would suggest that Lactobacillus brevis CD2 is effective in promoting oral health and preventing oral diseases. Significance: This study has the potential to contribute valuable information to the field of oral health, particularly in understanding how probiotics can be used as a preventive measure against oral diseases. If successful, the findings could lead to new recommendations for probiotic use in dental care routines.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 70
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Healthy volunteers of both sexes. - Dental caries experience (DMFT) less than 4. Exclusion Criteria: - Active or historical periodontitis. - Diabetes mellitus diagnosis. - Active or historical cancer diagnosis. - Antibiotic therapy within the past 3 months. - Currently undergoing active therapy with drugs. - Presence of disabilities affecting the ability to maintain oral hygiene at home. - Recent professional oral hygiene treatment within the last 3 months. - Pregnancy. - Presence of eating disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
L. Brevis CD2 DSM 27961
Participants will take four Mucomixx tablets (containing Lactobacillus brevis DSM 27961) daily for 28 days. The tablets should be taken after each of the following meals: breakfast, lunch, afternoon break, and dinner.
Placebo
Participants will take four placebo tablets daily for 28 days. The tablets should be taken after each of the following meals: breakfast, lunch, afternoon break, and dinner.

Locations

Country Name City State
Italy University of L'Aquila L'Aquila IT

Sponsors (1)

Lead Sponsor Collaborator
University of L'Aquila

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Salivary pH Assay used to define dental caries risk Baseline, 4 and 6 weeks
Primary Full mouth bleeding score Index used to quantify gingival inflammation (Percentage as Full mouth Bleeding score) Baseline, 4 and 6 weeks
Primary Full mouth plauqe score Index used to quantify individual capacity to home oral health (Percentage as Full mouth Plaque score) Baseline, 4 and 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06099574 - A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
Completed NCT00651248 - Evaluation of Salivary Flow and Buffer Capacity Associated to Aged People's Oral Health N/A
Completed NCT00299598 - Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations Phase 2
Completed NCT05046210 - The Effectiveness of Lay Health Advisors Strategy Intervention on Aborigines Elderly Oral Care Education N/A
Active, not recruiting NCT05124587 - Prediction for Critical Outcomes of Patients With COVID-19
Completed NCT03480516 - Comparison of Caries Arrested & Prevented Among SDF, NaF Varnish and Combination in Children N/A
Recruiting NCT04140929 - Oral Health Improvement for Nursing Home Residents Through Delegated Remotivation and Reinstruction N/A
Completed NCT05330793 - The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste N/A
Completed NCT04289337 - Double-blind Clinical Trials of Probiotic Products in Oral Health. N/A
Not yet recruiting NCT06073392 - Cluster RCT on the Effect of the Topics Number in Oral Health Educational Video Among Preschool Children. N/A
Completed NCT00103493 - Oral Health Education Program Phase 3
Enrolling by invitation NCT06080672 - The Effect of Disclosing Dental Plaque on Plaque Index and Gingival Index in Faculty of Dentistry Students N/A
Completed NCT05755152 - Fruit-based Chewing Gums for Improving Oral Health N/A
Completed NCT05515510 - Acceptance and Efficacy of a Digital Application Among Parents to Control Early Childhood Caries N/A
Completed NCT03587428 - Effect of Two Toothpastes on Bacteria in Saliva N/A
Active, not recruiting NCT01514552 - The Use of Functional Confections in Promoting Oral Health Phase 1
Enrolling by invitation NCT06124222 - Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC N/A
Completed NCT05695443 - Oral Health in Prison: a Study on Improving Prisoners' Oral Health N/A
Completed NCT03141554 - The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome Phase 4
Completed NCT03376022 - Attitudes and Knowledge of Oral Health Among Nursing Personnel